Disparities in Antiviral Treatment among Adults with Hepatitis B Cirrhosis: An Analysis of the National Veterans Affairs Cohort.

Timely antiviral therapy is critical in chronic hepatitis B (CHB) cirrhosis, to prevent further liver complications. Among a national cohort of US Veterans with CHB cirrhosis, only 52% were initiated on antiviral therapy; treatment was significantly lower among patients of non-Asian ethnicity, high-risk alcohol use, and in rural settings.